Hormone Receptor-Positive Breast Cancer | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Hormonal Therapy for Hormone Receptor-Positive Breast Cancer

Featuring perspectives from Dr Harold J Burstein, Ms Kelly Fischer, Dr Komal Jhaveri and Ms Melissa Rikal, including the following topics:

• Introduction (0:00)
• The Utility of Genomic Assays in Treatment Decision-Making for HR-Positive, HER2-Negative Localized Breast Cancer (10:21)
• The Role of CDK4/6 Inhibitors in Therapy for HR-Positive Breast Cancer (37:18)
• Oral Selective Estrogen Receptor Degraders in the Management of HR-Positive Metastatic Breast Cancer (mBC) (1:04:27)
• Alpelisib and Capivasertib in Treatment for HR-Positive mBC (1:28:40)

NCPD information and select publications